FDA Watch: Agency Launches Database of Complete Response Letters Sent to Drug Manufacturers About Initial Rejections
The early focus is on drug applications, but it could spread to the laboratory test approval process as well
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
The early focus is on drug applications, but it could spread to the laboratory test approval process as well
MFCU enforcement activity has rebounded from recent declines but still hasn’t reached pre-pandemic levels, according to a recent OIG report.
Thanks to recent federal enforcement initiatives, prompt response to patient PHI requests should be a growing priority for HIPAA compliance.
This month’s roundup includes the continued court battle between BGI and Illumina, an FCA lawsuit, and the latest version of OSHA’s COVID-19 rule.
Company involved in recent Class 1 recalls of COVID-19 rapid tests now faces further fallout by not refunding customers for faulty tests.
Starting April 4, Medicare beneficiaries can get eight free tests per month for each month the public health emergency remains in effect.
The relief package agreed to on April 4 appears to have become a collateral victim of a politically incendiary issue regarding immigration.
amesh “Sunny” Balwani’s legal team makes the case that Holmes is solely responsible for Theranos misdoings.
Legislation would require Medicare to cover genomic cancer testing and follow-up screening for those with a family history of cancer.
The ONC requested input on certification standards for the development and implementation of electronic prior authorization IT products.
A new case from the US Court of Appeals for the Ninth Circuit tests how far the public disclosure bar goes.